• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

研究英国生物库中与前列腺癌发病率和死亡率相关的潜在新型生化因素。

Examination of potential novel biochemical factors in relation to prostate cancer incidence and mortality in UK Biobank.

机构信息

Cancer Epidemiology Unit, Nuffield Department of Population Health, University of Oxford, Oxford, UK.

Clinical Trial Service Unit and Epidemiological Studies Unit, Nuffield Department of Population Health, University of Oxford, Oxford, UK.

出版信息

Br J Cancer. 2020 Dec;123(12):1808-1817. doi: 10.1038/s41416-020-01081-3. Epub 2020 Sep 23.

DOI:10.1038/s41416-020-01081-3
PMID:32963348
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7722733/
Abstract

BACKGROUND

Although prostate cancer is a leading cause of cancer death, its aetiology is not well understood. We aimed to identify novel biochemical factors for prostate cancer incidence and mortality in UK Biobank.

METHODS

A range of cardiovascular, bone, joint, diabetes, renal and liver-related biomarkers were measured in baseline blood samples collected from up to 211,754 men at recruitment and in a subsample 5 years later. Participants were followed-up via linkage to health administrative datasets to identify prostate cancer cases. Hazard ratios (HRs) and 95% confidence intervals were calculated using multivariable-adjusted Cox regression corrected for regression dilution bias. Multiple testing was accounted for by using a false discovery rate controlling procedure.

RESULTS

After an average follow-up of 6.9 years, 5763 prostate cancer cases and 331 prostate cancer deaths were ascertained. Prostate cancer incidence was positively associated with circulating vitamin D, urea and phosphate concentrations and inversely associated with glucose, total protein and aspartate aminotransferase. Phosphate and cystatin-C were the only biomarkers positively and inversely, respectively, associated with risk in analyses excluding the first 4 years of follow-up. There was little evidence of associations with prostate cancer death.

CONCLUSION

We found novel associations of several biomarkers with prostate cancer incidence. Future research will examine associations by tumour characteristics.

摘要

背景

尽管前列腺癌是癌症死亡的主要原因,但它的病因尚不清楚。我们旨在英国生物银行中确定与前列腺癌发病和死亡相关的新的生化因素。

方法

在招募时,从多达 211754 名男性的基线血液样本中测量了一系列心血管、骨骼、关节、糖尿病、肾脏和肝脏相关的生物标志物,并在 5 年后的亚样本中进行了测量。通过与健康管理数据集的链接对参与者进行随访,以确定前列腺癌病例。使用多变量调整的 Cox 回归校正回归稀释偏差计算危险比(HR)和 95%置信区间。通过使用错误发现率控制程序来解释多重检验。

结果

平均随访 6.9 年后,确定了 5763 例前列腺癌病例和 331 例前列腺癌死亡病例。前列腺癌的发病率与循环维生素 D、尿素和磷酸盐浓度呈正相关,与葡萄糖、总蛋白和天冬氨酸氨基转移酶呈负相关。在排除前 4 年随访的分析中,磷酸盐和半胱氨酸蛋白酶 C 是唯一与风险呈正相关和负相关的生物标志物。几乎没有证据表明与前列腺癌死亡有关。

结论

我们发现了几种生物标志物与前列腺癌发病之间的新关联。未来的研究将通过肿瘤特征来检验这些关联。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d1f6/7722733/cf04aca16c7d/41416_2020_1081_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d1f6/7722733/89b00163fbb5/41416_2020_1081_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d1f6/7722733/b57314f07e01/41416_2020_1081_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d1f6/7722733/cf04aca16c7d/41416_2020_1081_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d1f6/7722733/89b00163fbb5/41416_2020_1081_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d1f6/7722733/b57314f07e01/41416_2020_1081_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d1f6/7722733/cf04aca16c7d/41416_2020_1081_Fig3_HTML.jpg

相似文献

1
Examination of potential novel biochemical factors in relation to prostate cancer incidence and mortality in UK Biobank.研究英国生物库中与前列腺癌发病率和死亡率相关的潜在新型生化因素。
Br J Cancer. 2020 Dec;123(12):1808-1817. doi: 10.1038/s41416-020-01081-3. Epub 2020 Sep 23.
2
Circulating 25-Hydroxyvitamin D Concentration and Risk of Breast, Prostate, and Colorectal Cancers: The Melbourne Collaborative Cohort Study.循环 25-羟维生素 D 浓度与乳腺癌、前列腺癌和结直肠癌风险:墨尔本协作队列研究。
Cancer Epidemiol Biomarkers Prev. 2019 May;28(5):900-908. doi: 10.1158/1055-9965.EPI-18-1155. Epub 2019 Mar 6.
3
Prospective analyses of testosterone and sex hormone-binding globulin with the risk of 19 types of cancer in men and postmenopausal women in UK Biobank.前瞻性分析英国生物库中男性和绝经后女性的睾酮和性激素结合球蛋白与 19 种癌症风险的关系。
Int J Cancer. 2021 Aug 1;149(3):573-584. doi: 10.1002/ijc.33555. Epub 2021 Mar 31.
4
Circulating insulin-like growth factor-I, total and free testosterone concentrations and prostate cancer risk in 200 000 men in UK Biobank.在 UK Biobank 中 20 万男性中循环胰岛素样生长因子-I、总睾酮和游离睾酮浓度与前列腺癌风险的关系。
Int J Cancer. 2021 May 1;148(9):2274-2288. doi: 10.1002/ijc.33416. Epub 2020 Dec 11.
5
Prospective investigation of risk factors for prostate cancer in the UK Biobank cohort study.英国生物银行队列研究中前列腺癌风险因素的前瞻性调查。
Br J Cancer. 2017 Nov 7;117(10):1562-1571. doi: 10.1038/bjc.2017.312. Epub 2017 Sep 14.
6
Circulating liver enzymes and risks of chronic diseases and mortality in the prospective EPIC-Heidelberg case-cohort study.前瞻性 EPIC-Heidelberg 病例-队列研究中循环肝酶与慢性病和死亡率的关系。
BMJ Open. 2020 Mar 8;10(3):e033532. doi: 10.1136/bmjopen-2019-033532.
7
Hematologic Markers and Prostate Cancer Risk: A Prospective Analysis in UK Biobank.血液标志物与前列腺癌风险:英国生物库的前瞻性分析。
Cancer Epidemiol Biomarkers Prev. 2020 Aug;29(8):1615-1626. doi: 10.1158/1055-9965.EPI-19-1525. Epub 2020 May 26.
8
Prostate cancer screening in the randomized Prostate, Lung, Colorectal, and Ovarian Cancer Screening Trial: mortality results after 13 years of follow-up.随机前列腺癌、肺癌、结直肠癌和卵巢癌筛查试验中的前列腺癌筛查:13 年随访后的死亡率结果。
J Natl Cancer Inst. 2012 Jan 18;104(2):125-32. doi: 10.1093/jnci/djr500. Epub 2012 Jan 6.
9
Adiposity and risk of prostate cancer death: a prospective analysis in UK Biobank and meta-analysis of published studies.肥胖与前列腺癌死亡风险:英国生物银行前瞻性分析和已发表研究的荟萃分析。
BMC Med. 2022 May 5;20(1):143. doi: 10.1186/s12916-022-02336-x.
10
Serum vitamin D and risk of prostate cancer in a case-control analysis nested within the European Prospective Investigation into Cancer and Nutrition (EPIC).在欧洲癌症与营养前瞻性调查(EPIC)中的一项病例对照分析中,血清维生素D与前列腺癌风险的关系
Am J Epidemiol. 2009 May 15;169(10):1223-32. doi: 10.1093/aje/kwp022. Epub 2009 Apr 9.

引用本文的文献

1
Effect of Inorganic Phosphorus Manipulation on the Growth and Progression of Prostate Cancer Cells In Vitro.无机磷调控对前列腺癌细胞体外生长和进展的影响
Int J Mol Sci. 2025 May 16;26(10):4762. doi: 10.3390/ijms26104762.
2
NCAPD3-mediated AKT activation regulates prostate cancer progression.NCAPD3介导的AKT激活调节前列腺癌进展。
FASEB Bioadv. 2025 Jan 7;7(2):e1488. doi: 10.1096/fba.2024-00073. eCollection 2025 Feb.
3
Understanding the role of metabolic syndrome in prostate cancer risk: A UK Biobank prospective cohort study.

本文引用的文献

1
Comparison of risk factor associations in UK Biobank against representative, general population based studies with conventional response rates: prospective cohort study and individual participant meta-analysis.在常规应答率的情况下,与具有代表性的、基于一般人群的研究相比,英国生物银行中风险因素相关性的比较:前瞻性队列研究和个体参与者荟萃分析。
BMJ. 2020 Feb 12;368:m131. doi: 10.1136/bmj.m131.
2
Hormone-related diseases and prostate cancer: An English national record linkage study.激素相关疾病与前列腺癌:一项英国全国性的记录链接研究。
Int J Cancer. 2020 Aug 1;147(3):803-810. doi: 10.1002/ijc.32808. Epub 2019 Dec 11.
3
Hyperglycemia, Classified with Multiple Biomarkers Simultaneously in Men without Diabetes, and Risk of Fatal Prostate Cancer.
了解代谢综合征在前列腺癌风险中的作用:一项英国生物银行前瞻性队列研究。
Sci Rep. 2025 Jan 17;15(1):2345. doi: 10.1038/s41598-025-85501-5.
4
Severe obesity, high inflammation, insulin resistance with risks of all-cause mortality and all-site cancers, and potential modification by healthy lifestyles.重度肥胖、高炎症反应、胰岛素抵抗与全因死亡率及所有部位癌症风险相关,且可能受健康生活方式影响。
Sci Rep. 2025 Jan 9;15(1):1472. doi: 10.1038/s41598-025-85519-9.
5
Investigating causal relationships of blood and urine biomarkers with urological cancer risks: a mendelian randomization study and colocalization analyses.探究血液和尿液生物标志物与泌尿系统癌症风险之间的因果关系:一项孟德尔随机化研究和共定位分析。
J Cancer. 2025 Jan 1;16(3):1020-1031. doi: 10.7150/jca.103669. eCollection 2025.
6
Validation of candidate protein biomarkers previously identified by genetic instruments for prostate cancer risk: A prospective cohort analysis of directly measured protein levels in the ARIC study.验证先前通过遗传工具鉴定的前列腺癌风险候选蛋白生物标志物:ARIC 研究中直接测量的蛋白水平的前瞻性队列分析。
Prostate. 2024 Nov;84(15):1355-1365. doi: 10.1002/pros.24774. Epub 2024 Aug 15.
7
Stacked neural network for predicting polygenic risk score.堆叠神经网络预测多基因风险评分。
Sci Rep. 2024 May 21;14(1):11632. doi: 10.1038/s41598-024-62513-1.
8
Associations of serum cystatin C concentrations with total mortality and mortality of 12 site-specific cancers.血清胱抑素C浓度与全因死亡率及12种特定部位癌症死亡率的关联。
Front Mol Biosci. 2024 Apr 25;11:1209349. doi: 10.3389/fmolb.2024.1209349. eCollection 2024.
9
Liver Fibrosis Scores and Prostate Cancer Risk and Mortality in the Atherosclerosis Risk in Communities Study.肝脏纤维化评分与前列腺癌风险和死亡率:社区动脉粥样硬化风险研究。
Cancer Prev Res (Phila). 2023 Sep 1;16(9):523-530. doi: 10.1158/1940-6207.CAPR-23-0168.
10
Plasma total cholesterol concentration and risk of higher-grade prostate cancer: A nested case-control study and a dose-response meta-analysis.血浆总胆固醇浓度与高级别前列腺癌风险:巢式病例对照研究和剂量反应荟萃分析。
Int J Cancer. 2023 Oct 1;153(7):1337-1346. doi: 10.1002/ijc.34621. Epub 2023 Jun 12.
男性非糖尿病患者中同时存在多种生物标志物的高血糖与致命性前列腺癌风险。
Cancer Prev Res (Phila). 2019 Feb;12(2):103-112. doi: 10.1158/1940-6207.CAPR-18-0216. Epub 2018 Dec 11.
4
A Collaborative Analysis of Individual Participant Data from 19 Prospective Studies Assesses Circulating Vitamin D and Prostate Cancer Risk.19 项前瞻性研究的个体参与者数据的协作分析评估了循环维生素 D 与前列腺癌风险的关系。
Cancer Res. 2019 Jan 1;79(1):274-285. doi: 10.1158/0008-5472.CAN-18-2318. Epub 2018 Nov 13.
5
Mendelian randomization does not support serum calcium in prostate cancer risk.孟德尔随机化不支持血清钙与前列腺癌风险之间的关联。
Cancer Causes Control. 2018 Nov;29(11):1073-1080. doi: 10.1007/s10552-018-1081-5. Epub 2018 Oct 10.
6
Is nonalcoholic fatty liver disease associated with the development of prostate cancer? A nationwide study with 10,516,985 Korean men.非酒精性脂肪性肝病与前列腺癌的发展有关吗?一项针对 10516985 名韩国男性的全国性研究。
PLoS One. 2018 Sep 19;13(9):e0201308. doi: 10.1371/journal.pone.0201308. eCollection 2018.
7
Low Free Testosterone and Prostate Cancer Risk: A Collaborative Analysis of 20 Prospective Studies.游离睾酮水平低与前列腺癌风险:20 项前瞻性研究的协作分析。
Eur Urol. 2018 Nov;74(5):585-594. doi: 10.1016/j.eururo.2018.07.024. Epub 2018 Aug 1.
8
Serum inflammatory markers in relation to prostate cancer severity and death in the Swedish AMORIS study.血清炎症标志物与瑞典 AMORIS 研究中前列腺癌严重程度和死亡的关系。
Int J Cancer. 2018 Jun 1;142(11):2254-2262. doi: 10.1002/ijc.31256. Epub 2018 Jan 26.
9
Collider scope: when selection bias can substantially influence observed associations.碰撞范围:当选择偏差可能对观察到的关联产生实质性影响时。
Int J Epidemiol. 2018 Feb 1;47(1):226-235. doi: 10.1093/ije/dyx206.
10
Prospective investigation of risk factors for prostate cancer in the UK Biobank cohort study.英国生物银行队列研究中前列腺癌风险因素的前瞻性调查。
Br J Cancer. 2017 Nov 7;117(10):1562-1571. doi: 10.1038/bjc.2017.312. Epub 2017 Sep 14.